DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)

71.79 -1.34 (-1.83%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AZN $71.79 -1.83%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $71.28
Previous Close $73.13
Daily Range $71.05 - $72.43
52-Week Range $64.26 - $82.68
Market Cap $90.7B
P/E Ratio 35.85
Dividend (Yield) $3.80 (3.8%)
Ex-Dividend Date
Dividend Pay Date
02/18/15
03/23/15
Volume 1,876,593
Average Daily Volume 1,224,198
Current FY EPS $4.22

Sector

Healthcare

Industry

Drug Makers

AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website: http://www.astrazeneca.com/

News & Commentary

AstraZeneca plc Has a Rocky First-Quarter: Here's What You Need to Know

AstraZeneca reported another tough quarter today, reflecting the loss of exclusivity for top-selling drugs such as Nexium. Even so, there were some important developments and bright spots during the quarter.

AstraZeneca Inks Multiple Deals, Immuno-Oncology in Focus - Analyst Blog

AstraZeneca's (AZN) CEO Pascal Soriot on Q1 2015 Results - Earnings Call Transcript

Health Care Sector Update for 04/24/2015: CELG, EHTH, AERI

European Equities Close the Week Higher as German Business Optimism Grows

Illumina's Earnings Set Positive Tone for Biotech

What's behind Illumina's remarkable earnings beat, and what could it mean for biotech stocks?

Pfizer's Once And Future Deals

Stocks: 6 things to know before the open

Premarkets: 6 things to know before the open

Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?

Immuno-oncology has become a major focus among big pharma companies these days. Should investors jump on this trend?

Novavax Is Our Favorite Idea That Everyone Knows, But That No One Understands

See More AZN News...

AZN's Top Competitors

AZN $71.79 (-1.83%)
Current stock: AZN
JNJ $101.08 (0.62%)
Current stock: JNJ
PFE $35.27 (-0.25%)
Current stock: PFE
NVS $104.28 (-1.16%)
Current stock: NVS